Back to search

Peptide record

TPDB05684

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05684
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP Peptipedia
standard
No
A 9-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, and Peptipedia, with an available 3D structural model.
Sequence
EPFKLSLHL
Physicochemical Analysis
C52H82N12O13
ARNDCQGIMTWYV
L
1083.30
7.82
2
1
4
+0
1.74
0.133
130.00
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
1
H
0
I
3
L
1
K
0
M
1
F
1
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 1 I: 0 L: 3 K: 1 M: 0 F: 1 P: 1 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
9
C52H82N12O13
1083.30
7.82
+0
1.74
0.133
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
30 µg/mL

Target

Staphylococcus aureus ATCC 6535

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P.
Evidence 2 Activity

Activity

MIC
Antibacterial
30 µg/mL

Target

S. saprophyticus

Source & Reference

dbAMP

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/
Evidence 3 Activity

Activity

MIC
Antibacterial
15 µg/mL

Target

Escherichia coli CCT 1371

Source & Reference

dbAMP

Other

eria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the
Evidence 4 Activity

Activity

MIC
Antibacterial
30 µg/mL

Target

P. aeruginsa ACCT 27853

Source & Reference

dbAMP

Other

l), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the workers and secreted into Royal Jelly. Comp
Evidence 5 Activity

Activity

MIC
Antifungal
30 µg/mL

Target

Staphylococcus aureus ATCC 6535

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P.
Evidence 6 Activity

Activity

MIC
Antifungal
30 µg/mL

Target

S. saprophyticus

Source & Reference

dbAMP

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/
Evidence 7 Activity

Activity

MIC
Antifungal
15 µg/mL

Target

Escherichia coli CCT 1371

Source & Reference

dbAMP

Other

eria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the
Evidence 8 Activity

Activity

MIC
Antifungal
30 µg/mL

Target

P. aeruginsa ACCT 27853

Source & Reference

dbAMP

Other

l), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the workers and secreted into Royal Jelly. Comp
Evidence 9 Activity

Activity

MIC
Antiparasitic
30 µg/mL

Target

Staphylococcus aureus ATCC 6535

Source & Reference

NA

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P.
Evidence 10 Activity

Activity

MIC
Antiparasitic
30 µg/mL

Target

S. saprophyticus

Source & Reference

NA

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/
Evidence 11 Activity

Activity

MIC
Antiparasitic
15 µg/mL

Target

Escherichia coli CCT 1371

Source & Reference

NA

Other

eria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the
Evidence 12 Activity

Activity

MIC
Antiparasitic
30 µg/mL

Target

P. aeruginsa ACCT 27853

Source & Reference

NA

Other

l), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the workers and secreted into Royal Jelly. Comp
Evidence 13 Activity

Activity

MIC
Antiviral
30 µg/mL

Target

Staphylococcus aureus ATCC 6535

Source & Reference

NA

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P.
Evidence 14 Activity

Activity

MIC
Antiviral
30 µg/mL

Target

S. saprophyticus

Source & Reference

NA

Other

Active against G+ bacteria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/
Evidence 15 Activity

Activity

MIC
Antiviral
15 µg/mL

Target

Escherichia coli CCT 1371

Source & Reference

NA

Other

eria S. aureus ATCC 6535 (MIC 30 ug/ml), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the
Evidence 16 Activity

Activity

MIC
Antiviral
30 µg/mL

Target

P. aeruginsa ACCT 27853

Source & Reference

NA

Other

l), S. saprophyticus (MIC 30 ug/ml), and G- bacteria E. coli CCT 1371 (MIC 15 ug/ml), and P. aeruginsa ACCT 27853 (MIC 30 ug/ml). Jelleines are produced constitutively by the workers and secreted into Royal Jelly. Comp